Back to
FMR LLC
REGNShowing 8 of 28 quarters
Position history for
FMR LLC's holdings in Regeneron Pharmaceuticals, Inc.
Yes. FMR holds 831,964 shares of REGN (Regeneron Pharmaceuticals), worth $518.8M, as of its Q2 2026 13F filing. It reduced the position by 686,228 shares (-45.2%) from Q1 2026. FMR has held REGN in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$518.8M
Current Shares
831,964
Total Value Change
-$10.4B
Total Shares Change
-9.5M
Quarter-by-Quarter History
Other major holders of REGN: VANGUARD GROUP INC, BlackRock, Inc., BlackRock Finance, Inc., JPMORGAN CHASE & CO